Betaserc 8 mg, Tabletten
7680361190126
CH-36119
Tabletten
Associated product:
BETASERC cpr 8 mg 50 pce
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
8.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
cysteini hydrochloridum monohydricum
|
- | Substance | HIMDK |
|
E 310
|
- | Substance | ANTOX |
Reimbursement information
Public price
CHF 13.25
Specialties list
Yes
Generic
No
SL addition date:
15/03/1973
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 36119
- Drug name
- Betaserc, Tabletten
- Galenic form
- TAB
- ATC Code
- N07CA01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 20/12/1971
- Authorization expiration date
- 31/12/9999
- IT Number
- 02.04.4.
- Domain
- Human medicine
Package details
- Description (FR)
- BETASERC cpr 8 mg 50 pce
- Description (DE)
- BETASERC Tabl 8 mg 50 Stk
- Market launch
- 20/12/1971
- Narcotic (BTM)
- No